You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Iodine I 131 Tositumomab

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Ann Arbor (Iodine I 131 Tositumomab)

Active, not recruiting
Has Results
  • Multiple Myeloma
  • Iodine I 131 Tositumomab
  • Ann Arbor, Michigan
    University of Michigan
Mar 16, 2022

Follicular Lymphoma Trial in Chicago (Bortezomib and Tositumomab I-131)

Terminated
Has Results
  • Follicular Lymphoma
  • Bortezomib and Tositumomab I-131
  • Chicago, Illinois
    Rush University Medical Center
Oct 6, 2021

Mantle Cell Lymphoma Trial in United States (R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.)

Active, not recruiting
  • Mantle Cell Lymphoma
  • R-CHOP-14R-HIDAC,followed by RIT/HDT/ASCR.
  • Basking Ridge, New Jersey
  • +4 more
Dec 1, 2022

Renal Tracer Elimination in Thyroid Cancer Patients Treated With

Completed
  • Thyroid Carcinoma
    • Jena, Thüringen, Germany
      University Hospital Jena
    Dec 15, 2022

    Neuroblastoma, Childhood Metastatic Pheochromocytoma Trial in Philadelphia (131 I-Metaiodobenzylguanidine (131 I-MIBG), 131

    Available
    • Neuroblastoma
    • Childhood Metastatic Pheochromocytoma
    • 131 I-Metaiodobenzylguanidine (131 I-MIBG)
    • 131 I-MIBG
    • Philadelphia, Pennsylvania
      The Children's Hospital of Philadelphia
    Jul 11, 2022

    Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

    Not yet recruiting
    • Thyroid Cancer
    • +5 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Dec 20, 2022

    Lymphoma, Mantle-Cell Trial (Tositumomab and Iodine I 131 Tositumomab followed by CHOP)

    Completed
    Has Results
    • Lymphoma, Mantle-Cell
    • Tositumomab and Iodine I 131 Tositumomab followed by CHOP
    • (no location specified)
    Nov 19, 2019

    Thyroid Cancer Trial in New York (131 I-iodine (131-I), 124 I-iodine (124-I))

    Active, not recruiting
    • Thyroid Cancer
    • 131 I-iodine (131-I), 124 I-iodine (124-I)
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Apr 1, 2022

    Thyroid Cancer Trial in Bialystok (metformin, Radioactive iodine (I-131))

    Not yet recruiting
    • Thyroid Cancer
    • Bialystok, Poland
      Department of Endocrinology, Diabetology and Internal Medicine,
    Jul 26, 2022

    Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Non-Hodgkin Trial in United States (Autologous transplantation

    Completed
    Has Results
    • Lymphoma, B-Cell
    • +2 more
    • Autologous transplantation using rituxan/BEAM
    • Autologous transplantation using Bexxar/BEAM
    • New Haven, Connecticut
    • +35 more
    Oct 21, 2021

    Kidney Cancer Trial in New York (Iodine-131 radiolabeled chimeric mAb G250 (131I-cG250))

    Completed
    Has Results
    • Kidney Cancer
    • Iodine-131 radiolabeled chimeric monoclonal antibody G250 (131I-cG250)
    • New York, New York
      Memorial Sloan-Kettering Cancer Center
    Oct 3, 2022

    Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)

    Active, not recruiting
    • Brain and Central Nervous System Tumors
    • +9 more
    • DNA analysis
    • +4 more
    • New York, New York
      Memorial Sloan Kettering Cancer Center
    Oct 28, 2021

    Thyroid Nodule, Toxic or With Hyperthyroidism, Autonomous Thyroid Function, Thyroid Nodule; Hyperthyroidism Trial in Arnhem,

    Recruiting
    • Thyroid Nodule, Toxic or With Hyperthyroidism
    • +5 more
    • Radiofrequency ablation
    • Radioactive iodine
    • Arnhem, Gelderland, Netherlands
    • +1 more
    Dec 2, 2021

    Colorectal Tumors Trial in Heidelberg (Capecitabine, 131I-huA33 (131-Iodine on humanised mAb A33))

    Completed
    Has Results
    • Colorectal Neoplasms
    • Capecitabine
    • 131I-huA33 (131-Iodine on humanised monoclonal antibody A33)
    • Heidelberg, Victoria, Australia
      Ludwig Institute Oncology Unit and Tumor Targeting Program, Aust
    Jan 11, 2022

    Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult

    Terminated
    • Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
    • +9 more
    • Allogeneic Bone Marrow Transplantation
    • +7 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Oct 4, 2021

    Thyroid Cancer Trial in Peking (Apatinib)

    Completed
    • Thyroid Cancer
    • Peking, China
      Peking Union Medical College Hospital
    Jan 18, 2022

    Disseminated Neuroblastoma, Ganglioneuroblastoma, Localized Resectable Neuroblastoma Trial in United States (drug, radiation,

    Active, not recruiting
    Has Results
    • Disseminated Neuroblastoma
    • +5 more
    • Birmingham, Alabama
    • +22 more
    Mar 3, 2022

    Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation Trial in Villejuif (Trametinib,

    Active, not recruiting
    • Metastatic Radioactive Iodine Refractory Thyroid Cancer Patients With RAS or BRAF Mutation
    • Villejuif, Val De Marne, France
      Gustave Roussy
    Sep 27, 2021

    Non Toxic Multinodular Goiter, High Intensity Focused Ultrasound, RAI Trial in Hong Kong (Echopulse, Radioactive iodine

    Not yet recruiting
    • Non Toxic Multinodular Goiter
    • +2 more
    • Echopulse
    • Radioactive iodine (Radioidine i131)
    • Hong Kong, Hong Kong
      Queen Mary Hospital
    Apr 27, 2021

    Lymphoma Trial in United States (biological, drug, radiation)

    Active, not recruiting
    Has Results
    • Lymphoma
    • rituximab
    • +5 more
    • Anchorage, Alaska
    • +258 more
    Sep 23, 2022

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Hodgkin Lymphoma, Recurrent T-Cell Non-Hodgkin Lymphoma Trial in Seattle

    Terminated
    Has Results
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +5 more
    • Autologous Hematopoietic Stem Cell Transplantation
    • +2 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    Mar 26, 2020

    Head Neck Cancer Trial in United Kingdom (recombinant thyroid-stimulating hormone, Radiodine ablation without rhTSH)

    Active, not recruiting
    • Head and Neck Cancer
    • recombinant thyroid-stimulating hormone
    • Radiodine ablation without rhTSH
    • Brighton, England, United Kingdom
    • +24 more
    Oct 13, 2021

    Iodine-131 in Total(Near) Thyroidectomy Patients.

    Completed
    • Thyroidectomy
      • New Taipei City, Taiwan
        Far Eastern Memorial Hospital
      Feb 22, 2022

      Thyroid Disease Trial in Syracuse (SPECT)

      Enrolling by invitation
      • Thyroid Disease
      • SPECT
      • Syracuse, New York
        SUNY Upstate Medical University
      Aug 31, 2023

      Differentiated Thyroid Cancer Trial (Low iodine diet)

      Not yet recruiting
      • Differentiated Thyroid Cancer
      • Low iodine diet
      • (no location specified)
      Oct 25, 2022